News

The world of Kedrion Biopharma at a glance:
discover the latest
up-to-date news.

2024 in review: achieving +10% growth and unveiling our new identity 14-04-2025 2024 in review: achieving +10% growth and unveiling our new identity Read the news
Kedrion Expands Ryplazim Distribution Network for PLGD-1 Patients 21-03-2025 Kedrion Expands Ryplazim Distribution Network for PLGD-1 Patients Read the news
FDA Approves Kedrion's Bolognana Facility for Production of First and Only Treatment for PLGD-1, Ryplazim® 20-11-2024 FDA Approves Kedrion's Bolognana Facility for Production of First and Only Treatment for PLGD-1, Ryplazim® Read the news
2023 Annual Report
The 2023 Annual Report is out!
Are you curious to discover why we named it «Continuing a Journey of Science and Humanity»?
Hop on and click here to join us in the journey.
Read more
shield-1
Pharmacovigilance
genetics-1
Medical & Scientific Information